Drug Therapy

Oral Trimethoprim/Sulfamethoxazole in the Treatment of Acne Vulgaris

Cutis. 2007 June;79(6):430-434
By
Bhambri S
Del Rosso Jq
Desai A
Author and Disclosure Information

Oral trimethoprim/sulfamethoxazole (TMP-SMX) is approved by the US Food and Drug Administration for the treatment of urinary tract infections, shigellosis, acute otitis media in pediatric patients, and Pneumocystis carinii pneumonia. TMP-SMX has been used off label in dermatology to treat various skin conditions, including acne vulgaris and other skin and soft tissue infections, especially those infections caused by methicillin-resistant Staphylococcus aureus.
PDF Download

 

Recommended Reading

Light Therapy Underwhelming for Acne
MDedge Dermatology
Corrective Camouflage in Pediatric Dermatology
MDedge Dermatology
The Role of Chlamydia pneumoniae in the Etiology of Acne Rosacea: Response to the Use of Oral Azithromycin
MDedge Dermatology
A Review of Azithromycin for the Treatment of Acne Vulgaris
MDedge Dermatology
The Use of Azelaic Acid 15% Gel, Topical Retinoids, and Photoprotection in the Management of Rosacea and Comorbid Dermatologic Disorders
MDedge Dermatology
Adapalene 0.1% Gel in Combination With Microdermabrasion to Treat Acne
MDedge Dermatology
Hypertrophic Scars and Keloids: What Can Lasers Do?
MDedge Dermatology
iPLEDGE at 6 Months
MDedge Dermatology
Treatment of Acne Vulgaris With Photodynamic Therapy: The Use of Aminolevulinic Acid and Green Light
MDedge Dermatology
A Study of 5.5% Benzoyl Peroxide Microsphere Cream Versus 6% Benzoyl Peroxide Gel in the Treatment of Acne Vulgaris
MDedge Dermatology